Pneumocystis Carinii Therapy
Piperazine-linked bisbenzamidines active against Pneumocystis carinii
Published in TB and Outbreaks Week, February 8th, 2005
"Trimethoprim-sulfamethoxazole and pentamidine isethionate have been used extensively for the prophylaxis and therapy of pneumonia caused by Pneumoeystis jirovecii Problems associated with toxicity and potential emerging resistance for both therapies necessitate the development of safe and effective analogs or new treatment strategies.
"In the present study, a library of 36 compounds was synthesized by using the pentamidine molecule as the parent compound modified by a 1,4-piperazinediyl moiety as the central linker to restrict conformation flexibility. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Diagnostics
Immunochromatographic assay distinguishes C. albicans & C. dubliniensis - Methicillin-Resistant Staphylococcus Aureus
EMSRA strain tracked from one hospital as it spread to surrounding hospitals - Mycobacterium Tuberculosis
Mycobacterium tuberculosis Cameroon family is molecularly characterized - SARS Outbreak
Strict infection control is an effective intervention following SARS exposure - Acinetobacter Baumannii
Multiresistant Acinetobacter baumannii clone identified in 24 hospitals - Aflatoxin Exposure
Aflatoxin exposure and toxicity add to disease burden in developing countries - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
